MediWound (MDWD) Gross Profit Growth (3y) (2017 - 2025)

MediWound (MDWD) Gross Profit Growth (3y) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 54.36%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.16%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.86%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 79.18%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 MediWound 165.19 Mn 160.39 Mn 278,000.00 -67.58%

Historic Data

Download Data
DateValue
Dec 31, 2025 -67.58%
Sep 30, 2025 -28.33%
Jun 30, 2025 6.44%
Mar 31, 2025 -20.34%
Dec 31, 2024 -16.28%
Sep 30, 2024 -34.91%
Jun 30, 2024 -42.58%
Mar 31, 2024 -36.90%
Dec 31, 2023 -32.40%
Sep 30, 2023 -31.35%
Jun 30, 2023 -2.24%
Mar 31, 2023 -12.43%
Dec 31, 2022 96.09%
Sep 30, 2022 27.62%
Jun 30, 2022 -59.90%
Mar 31, 2022 111.65%
Dec 31, 2021 72.47%
Sep 30, 2021 73.26%
Jun 30, 2021 80.42%
Mar 31, 2021 159.04%